MiROSiGHT

MiROSiGHT, founded in April 2023, is a research and development enterprise focused on innovative medical devices in the field of brain science. It is committed to creating China's first comprehensive solution for cerebrospinal fluid management while simultaneously advancing cutting-edge products such as novel liquid embolic agents. The company’s core product pipeline includes intracranial pressure monitoring systems, hydrophilic-coated/drug-eluting external ventricular drainage systems, and adjustable pressure shunts, aiming to provide smarter, more precise, and safer device support for the diagnosis and treatment of brain diseases.